5-Nitrothiazol-2-amine

Suppliers

Names

[ CAS No. ]:
121-66-4

[ Name ]:
5-Nitrothiazol-2-amine

[Synonym ]:
2-Amino-5-nitrothiazole
2-Thiazolamine, 5-nitro-
5-nitro-2-thiazolylamin
5-Nitrothiazol-2-amine
5-Nitro-1,3-thiazol-2-amine
MFCD00005326
EINECS 204-490-9
2-AMINO-5-NITRO THIAZOLE

Chemical & Physical Properties

[ Density]:
1.7±0.1 g/cm3

[ Boiling Point ]:
345.1±15.0 °C at 760 mmHg

[ Melting Point ]:
195-200 °C (dec.)(lit.)

[ Molecular Formula ]:
C3H3N3O2S

[ Molecular Weight ]:
145.140

[ Flash Point ]:
162.5±20.4 °C

[ Exact Mass ]:
144.994598

[ PSA ]:
112.97000

[ LogP ]:
0.83

[ Vapour Pressure ]:
0.0±0.8 mmHg at 25°C

[ Index of Refraction ]:
1.705

[ Stability ]:
Stable. Incompatible with strong acids, strong oxidizing agents, acid chlorides, acid anhydrides.

[ Water Solubility ]:
<0.1 g/100 mL at 20 ºC

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XJ2800000
CHEMICAL NAME :
Thiazole, 2-amino-5-nitro-
CAS REGISTRY NUMBER :
121-66-4
BEILSTEIN REFERENCE NO. :
0126797
LAST UPDATED :
199710
DATA ITEMS CITED :
24
MOLECULAR FORMULA :
C3-H3-N3-O2-S
MOLECULAR WEIGHT :
145.15
WISWESSER LINE NOTATION :
T5N CSJ BZ DNW

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
28 gm/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - Carcinogenic by RTECS criteria Blood - leukemia Blood - lymphoma, including Hodgkin's disease
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
23 gm/kg/46W-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Kidney, Ureter, Bladder - Kidney tumors Skin and Appendages - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
12 gm/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Reproductive - Tumorigenic effects - uterine tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
600 mg/kg
SEX/DURATION :
male 10 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland, accessory glands
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
700 mg/kg
SEX/DURATION :
male 14 day(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders

MUTATION DATA

TYPE OF TEST :
Mutation in mammalian somatic cells
TEST SYSTEM :
Rodent - mouse Lymphocyte
DOSE/DURATION :
15600 ug/L
REFERENCE :
EMMUEG Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.10- 1987- Volume(issue)/page/year: 12(Suppl 13),103,1988 *** REVIEWS *** IARC Cancer Review:Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 31,71,1983 IARC Cancer Review:Human No Adequate Data IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 31,71,1983 IARC Cancer Review:Group 3 IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,56,1987

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H315-H319-H335

[ Precautionary Statements ]:
P301 + P312 + P330-P305 + P351 + P338

[ Personal Protective Equipment ]:
dust mask type N95 (US);Eyeshields;Gloves

[ Hazard Codes ]:
Xn:Harmful

[ Risk Phrases ]:
R20/21/22;R40

[ Safety Phrases ]:
S26-S45-S24/25

[ RIDADR ]:
2811

[ WGK Germany ]:
3

[ RTECS ]:
XJ2800000

[ HS Code ]:
2934100090

Synthetic Route

Precursor & DownStream

Precursor

  • 2-Aminothiazole
  • N-(1,3-thiazol-2-yl)nitramide
  • Nithiamide
  • 2-acetamidothiazole
  • ethyl nitrate
  • (E)-N, N-DIMETHYL-2-NITROETHENAMINE

DownStream

  • Pentanamide,N-(5-nitro-2-thiazolyl)-
  • 1H-Isoindole-1,3(2H)-dione,4-nitro-2-(5-nitro-2-thiazolyl)-
  • 2-CHLORO-5-NITROTHIAZOLE
  • 2-Bromo-5-nitrothiazole
  • Nitazoxanide
  • 2-(5-nitro-thiazol-2-yl)-3a,4,7,7a-tetrahydro-4,7-methano-isoindole-1,3-dione
  • 4-fluoro-N-(5-nitro-1,3-thiazol-2-yl)benzamide
  • 2-Bromo-N-(5-nitrothiazol-2-yl)acetamide
  • 1-(2-chloroethyl)-3-(5-nitro-1,3-thiazol-2-yl)urea
  • 5-nitro-1,3-thiazole

Customs

[ HS Code ]: 2934100090

[ Summary ]:
2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

Articles

Evaluation of 2-amino-5-nitrothiazole as a hypoxic cell radiosensitizer.

Radiat. Res. 90(3) , 575-85, (1982)

Platinum complexes with one radiosensitizing ligand [PtCl2(NH3) (sensitizer)]: radiosensitization and toxicity studies in vitro.

Radiat. Res. 112(2) , 273-82, (1987)

Complexes of general formula [PtCl2(NH3)L] with one radiosensitizing ligand per platinum are compared with ligand L alone, complexes with two radiosensitizers per platinum [PtCl2L2], and their analogs...

2-amino-5-nitrothiazole.

IARC Monogr. Eval. Carcinog. Risk Chem. Hum. 31 , 71-7, (1983)


More Articles


Related Compounds

  • SU3327
  • 4-nitro-1,3-thiazol-2-amine
  • N-methyl-5-nitro-1,3-thiazol-2-amine
  • N-(5-nitrothiazol-2-yl)furan-2-carboxamide
  • N-[2-[(5-nitrothiazol-2-yl)azo]-5-[(phenylsulphonyl)amino]phenyl]acetamide
  • [[5-acetamido-4-[(5-nitrothiazol-2-yl)azo]-2-methoxyphenyl]imino]diethyl dipropionate
  • 1-methyl-2-[2-(1H-1,2,4-triazol-1-yl)ethyl]piperazine
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • Benzyl 4-[(5-bromothiophen-2-yl)sulfonyl]-1,4-diazepane-1-carboxylate
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 3-[2-(Dimethylamino)-3,4-difluorophenyl]azetidin-3-ol
  • 2-[1-(1-Benzothiophen-3-yl)cyclobutyl]ethan-1-amine
  • 2-(Chloromethyl)-1-propoxybutane
  • 6-[4-[(5-Chloropyrimidin-2-yl)-methylamino]piperidin-1-yl]-3-methyl-1,3-diazinane-2,4-dione